Related references
Note: Only part of the references are listed.Cytochrome P-450 Polymorphisms and Response to Clopidogrel.
Jessica L. Mega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Residual platelet activity is increased in clopidogrel- and ASA-treated patients with coronary stenting for acute coronary syndromes compared with stable coronary artery disease
T. Geisler et al.
HEART (2008)
Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents
Dietmar Trenk et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial
Stephen D. Wiviott et al.
LANCET (2008)
CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation
Tobias Geisler et al.
PHARMACOGENOMICS (2008)
Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients - The EVASTENT matched-cohort registry
Jacques Machecourt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Clopidogrel non responsiveness in patients undergoing percutaneous coronary intervention with stenting: A systematic review and meta-analysis
Jaapjan D. Snoep et al.
AMERICAN HEART JOURNAL (2007)
Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis
Piergiovanni Buonamici et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Clinical end points in coronary stent trials - A case for standardized definitions
Donald E. Cutlip et al.
CIRCULATION (2007)
Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis
Alain Joel Nordmann et al.
EUROPEAN HEART JOURNAL (2006)
Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement
Willibald Hochholzer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation
Tobias Geisler et al.
EUROPEAN HEART JOURNAL (2006)
Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up
Duk-Woo Park et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome
T Cuisset et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Platelet reactivity in patients and recurrent events post-stenting - Results of the PREPARE POST-STENTlNG study
PA Gurbel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Clopidogrel effect on platelet REactivity in patients with stent thrombosis - Results of the CREST study
PA Gurbel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Stent thrombosis is associated with an impaired response to antiplatelet therapy
P Wenaweser et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention
W Hochholzer et al.
CIRCULATION (2005)
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents
I Iakovou et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Drug-eluting stent thrombosis -: Results from a pooled analysis including 10 randomized studies
R Moreno et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation
ATL Ong et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Variability in platelet responsiveness to clopidogrel among 544 individuals
VL Serebruany et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system
T Palmerini et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Predictors of subacute stent thrombosis - Results of a systematic intravascular ultrasound study
E Cheneau et al.
CIRCULATION (2003)
Clopidogrel for coronary stenting - Response variability, drug resistance, and the effect of pretreatment platelet reactivity
PA Gurbel et al.
CIRCULATION (2003)
Incidence of thrombotic occlusion and major adverse cardiac events between two and four weeks after coronary stent placement:: Analysis of 5,678 patients with a four-week ticlopidine regimen
H Schühlen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting
FJ Neumann et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement
I Muller et al.
HEART (2001)
Share Paper
